Revenue
No reported data
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2023
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Research & development | $4.1M | $3.6M | $3.5M | $1.0M | $1.0M |
| Operating expenses | $11.9M | $7.7M | $5.9M | $2.3M | $1.7M |
| Operating income | −$11.9M | −$7.7M | −$5.9M | −$2.3M | −$1.7M |
| EBITDAderived | −$11.6M | −$7.7M | — | — | — |
| Net income | −$11.7M | −$9.1M | −$6.6M | −$5.0M | −$1.2M |
| Basic EPSper diluted share | -$7.16 | -$79.65 | -$3.53 | -$5.04 | -$0.12 |
| Diluted EPSper diluted share | -$7.16 | -$82.60 | -$3.53 | -$5.04 | — |